Reorganisation of medical oncology departments during the novel coronavirus disease-19 pandemic: a nationwide Italian survey.,European Journal of Cancer

当前位置： X-MOL 学术 › Eur. J. Cancer › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Reorganisation of medical oncology departments during the novel coronavirus disease-19 pandemic: a nationwide Italian survey.
European Journal of Cancer ( IF 8.4 ) Pub Date : 2020-04-06 , DOI: 10.1016/j.ejca.2020.03.024
Alice Indini ₁ , Carlo Aschele ₂ , Luigi Cavanna ₃ , Mario Clerico ₄ , Bruno Daniele ₅ , Giammaria Fiorentini ₆ , Luisa Fioretto ₇ , Monica Giordano ₈ , Vincenzo Montesarchio ₉ , Cinzia Ortega ₁₀ , Graziella Pinotti ₁₁ , Alberto Scanni ₁₂ , Claudio Zamagni ₁₃ , Livio Blasi ₁₄ , Francesco Grossi ₁

Affiliation

Medical Oncology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Medical Oncology Department, Ospedale Sant'Andrea, La Spezia, Italy.
Oncology-Hematology Department, Hospital of Piacenza, Piacenza, Italy.
Medical Oncology Department ASL Biella, Biella, Italy.
Oncology Unit, Ospedale Del Mare, Naples, Italy.
Department of Oncology and Hematology, Ospedali Riuniti Marche Nord, Pesaro, Italy.
Department of Oncology, SM Annunziata Hospital, Florence, Italy.
Medical Oncology Division, ASST-Lariana, Como, Italy.
Oncology Unit, "Monaldi" Hospital, Naples, Italy.
Department of Medical Oncology, Ospedale S. Lazzaro ASL CN2 Alba-Bra, Cuneo, Italy.
Medical Oncology Department, ASST Sette Laghi, Varese, Italy.
Department of Medical Oncology, Fatebenefratelli e Oftalmico Hospital, Milan, Italy.
Medical Oncology Unit, S.Orsola-Malpighi Hospital, Bologna, Italy.
Medical Oncology Unit, ARNAS Civico, Palermo, Italy.

The novel severe acute respiratory syndrome coronavirus-2 pandemic is a global health problem, which started to affect China by the end of 2019. In Europe, Italy has faced this novel disease entity (named novel coronavirus disease [COVID-19]) first and severely. COVID-19 represents a significant hurdle for public health services and a potential harm for patients with cancer. The Collegio Italiano dei Primari Oncologi Medici (CIPOMO) is an Italian association of head physicians in oncology departments, which promotes working and research activities in oncology on a national basis. In the midst of the epidemic in Italy, the CIPOMO promoted a national survey aiming to evaluate the impact of COVID-19 on clinical activity of oncologists and the implementation of containment measures of COVID-19 diffusion. Overall, 122 head physicians participated in this survey, with a homogeneous distribution on the national territory. Results show that the following measures for oncologic patients have been promptly implemented through the whole country: use of protective devices, triage of patients accessing the hospital, delay of non-urgent visits and use of telemedicine. Results of this survey suggest that Italian oncology departments have promptly set a proactive approach to the actual emergency. Oncologists need to preserve the continuum of care of patients, as the benefit of ensuring a well-delivered anti-cancer treatment plan outweighs the risk of COVID-19 infection. International cooperation is an important starting point, as heavily affected nations can serve as an example to find out ways to safely preserve health activity during the pandemic.

更新日期：2020-04-06

点击分享查看原文

点击收藏

公开下载

阅读更多本刊最新论文本刊介绍/投稿指南

全部期刊列表>>